Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk

Affiliations

• ¹ Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse. corre.jill@iuct-oncopole.fr.
• ² Hematology Department, University Hospital, Amiens.
• ³ Biostatistics Department, Institut Claudius Regaud, IUCT-O, Toulouse.
• ⁴ Hematology Department, University Hospital, Nancy.
• ⁵ Hematology Department, University Hospital, Dijon.
• ⁶ Hematology Department, University Hospital, Poitiers.
• ⁷ Hematology Department, University Hospital, Créteil.
• ⁸ Hematology Department, University Hospital, Lille.
• ⁹ Hematology Department, University Hospital, Bordeaux.
• ¹⁰ Hematology Department, University Hospital, Paris.
• ¹¹ Hematology Department, University Hospital, Besancon.
• ¹² Hematology Department, University Hospital, Caen.
• ¹³ Hematology Department, University Hospital, Bobigny.
• ¹⁴ Hematology Department, University Hospital, Limoges.
• ¹⁵ Hematology Department, Institut Paoli Calmettes, Marseille.
• ¹⁶ Hematology Department, Department Hospital, Annecy.
• ¹⁷ Hematology Department, Department Hospital, Libourne.
• ¹⁸ Hematology Department, Department Hospital, Chalon-sur-Saône.
• ¹⁹ Hematology Department, Department Hospital, Valenciennes.
• ²⁰ Hematology Department, Department Hospital, Boulogne-Sur-Mer.
• ²¹ Hematology Department, Department Hospital, Dunkerque.
• ²² Hematology Department, Department Hospital, Mâcon.
• ²³ Hematology Department, Department Hospital, Roubaix.
• ²⁴ Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
• ²⁵ Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
• ²⁶ Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse.